Literature DB >> 1605221

Aarskog syndrome: the changing phenotype with age.

J P Fryns1.   

Abstract

We describe the Leuven experience with 52 males with Aarskog syndrome particularly with respect to clinical variability, changing phenotype with age, and previously unreported signs. At least 30% of affected males were mentally retarded, two thirds of them at the level of slight mental handicap. Hyperactive behavior and symptoms of attention deficit disorders were frequently observed (61% of the mentally normal and 84% of the mentally subnormal), but regressed completely after the age of 12 to 14 years. The social integration and functioning as adults is satisfactory. Postpubertal males with Aarskog syndrome have only minor remnant manifestations of the prepubertal phenotype, making clinical diagnosis in adults extremely difficult.

Entities:  

Mesh:

Year:  1992        PMID: 1605221     DOI: 10.1002/ajmg.1320430164

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Brief report: autism and Aarskog syndrome.

Authors:  F Assumpcao; R C Santos; M Rosario; M Mercadante
Journal:  J Autism Dev Disord       Date:  1999-04

2.  De Lange syndrome: subjective and objective comparison of the classical and mild phenotypes.

Authors:  J E Allanson; R C Hennekam; M Ireland
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

3.  Clinical utility gene card for: Aarskog-Scott syndrome (faciogenital dysplasia).

Authors:  Alfredo Orrico; Lucia Galli; Jill Clayton-Smith; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

4.  Intelligence and development in Aarskog syndrome.

Authors:  L J Logie; M E Porteous
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

5.  Faciogenital dysplasia protein (FGD1) regulates export of cargo proteins from the golgi complex via Cdc42 activation.

Authors:  Mikhail V Egorov; Mariagrazia Capestrano; Olesya A Vorontsova; Alessio Di Pentima; Anastasia V Egorova; Stefania Mariggiò; M Inmaculada Ayala; Stefano Tetè; Jerome L Gorski; Alberto Luini; Roberto Buccione; Roman S Polishchuk
Journal:  Mol Biol Cell       Date:  2009-03-04       Impact factor: 4.138

6.  Clinical utility gene card for: Aarskog-Scott Syndrome (faciogenital dysplasia) - update 2015.

Authors:  Alfredo Orrico; Lucia Galli; Jill Clayton-Smith; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

7.  Cerebrovascular disease associated with Aarskog-Scott syndrome.

Authors:  Michael L Diluna; Nduka M Amankulor; Michele H Johnson; Murat Gunel
Journal:  Neuroradiology       Date:  2007-02-10       Impact factor: 2.995

8.  Aarskog-Scott syndrome: clinical and molecular characterisation of a family with the coexistence of a novel FGD1 mutation and 16p13.11-p12.3 microduplication.

Authors:  Piero Pavone; Silvia Marino; Antonino Maniaci; Salvatore Cocuzza
Journal:  BMJ Case Rep       Date:  2020-06-30

9.  FGD1 Variant Associated With Aarskog-Scott Syndrome.

Authors:  Yilin Zhu; Qingqing Chen; Haiyan Lin; Huifei Lu; Yangbin Qu; Qingfeng Yan; Chunlin Wang
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

10.  Case Report: Aarskog-scott syndrome caused by FGD1 gene variation: A family study.

Authors:  Yijia Liang; Honglin Wu; Xiumei He; Xiyu He
Journal:  Front Genet       Date:  2022-08-16       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.